Twenty-four mini-pool HCV RNA screening in a routine clinical virology laboratory setting: A six-year prospective study

Journal of Virological Methods

Volumn 171, Issue 1, 2011, Pages 303-305

  Seme, Katja ^a   Močilnik, Tina ^a   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

HCV; Hepatitis C; Intravenous drug users; Mini pool; PCR; Screening

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ANALYTIC METHOD; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL LABORATORY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; LABORATORY AUTOMATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RNA ANALYSIS; SEROCONVERSION; VIROLOGY;

HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOASSAY; MASS SCREENING; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIROLOGY;

HEPATITIS C VIRUS;

EID: 78650585655     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.11.008     Document Type: Article

References (21)

1. Alter M.J., Seeff L.B., Bacon B.R., Thomas D.L., Rigsby M.O., Di Bisceglie A.M. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann. Intern. Med. 2004, 141:715-717.
2. Busch M.P., Glynn S.A., Stramer S.L., Strong D.M., Caglioti S., Wright D.J., Pappalardo B., Kleinman S.H., NHLBI-REDS NAT Study Group A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005, 45:254-264.
3. Chevaliez S., Pawlotsky J.M. Virological techniques for the diagnosis and monitoring of hepatitis B and C. Ann. Hepatol. 2009, 8:7-12.
4. Corey K.E., Mendez-Navarro J., Gorospe E.C., Zheng H., Chung R.T. Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis. J. Viral Hepat. 2010, 17:201-207.
5. Coste J., Reesink H.W., Engelfriet C.P., Laperche S., Brown S., Busch M.P., Cuijpers H.T., Elgin R., Ekermo B., Epstein J.S., Flesland O., Heier H.E., Henn G., Hernandez J.M., Hewlett I.K., Hyland C., Keller A.J., Krusius T., Levicnik-Stezinar S., Levy G., Lin C.K., Margaritis A.R., Muylle L., Niederhauser C., Pastila S., Pillonel J., Pineau J., van der Poel C.L., Politis C., Roth W.K., Sauleda S., Seed C.R., Sondag-Thull D., Stramer S.L., Strong M., Vamvakas E.C., Velati C., Vesga M.A., Zanetti A. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang. 2005, 88:289-303.
6. Cox A.L., Netski D.M., Mosbruger T., Sherman S.G., Strathdee S., Ompad D., Vlahov D., Chien D., Shyamala V., Ray S.C., Thomas D.L. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin. Infect. Dis. 2005, 40:951-958.
7. Dhumeaux D., Marcellin P., Lerebours E. Treatment of hepatitis C. The 2002 French consensus. Gut 2003, 52:1784-1787.
8. Ghany M.G., Strader D.B., Thomas D.L., Seeff L.B. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374. American Association for the Study of Liver Diseases.
9. Halfon P., Bourliere M., Penaranda G., Khiri H., Ouzan D. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J. Clin. Microbiol. 2006, 44:2507-2511.
10. Khan N., Aswad S., Shidban H., Aghajani M., Mendez R., Mendez R., Comanor L. Improved detection of HCV infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. J. Clin. Virol. 2004, 30:175-182.
11. Mine H., Emura H., Miyamoto M., Tomono T., Minegishi K., Murokawa H., Yamanaka R., Yoshikawa A., Nishioka K., Japanese Red Cross NAT Research Group High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J. Virol. Methods 2003, 112:145-151.
12. National Institutes of Health National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002 - June 10-12, 2002. Hepatology 2002, 6(5 Suppl. 1):S3-S20.
13. Roth W.K., Weber M., Buhr S., Drosten C., Weichert W., Sireis W., Hedges D., Seifried E. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion 2002, 42:862-868.
14. Scott J.D., Gretch D.R. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA 2007, 297:724-732.
15. Seme K., Poljak M., Babič D.Z., Močilnik T., Vince A. The role of core antigen detection in management of hepatitis C: a critical review. J. Clin. Virol. 2005, 32:92-101.
16. Seme K., Močilnik T., Fujs K., Babič D.Z., Todorović A., Fras-Stefan T., Poljak M. Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: Results of a two-year prospective study. J. Virol. Methods 2007, 140:218-221.
17. Seme K., Vrhovac M., Močilnik T., Matičič M., Lešničar G., Baklan Z., Meglič Volkar J., Rajter M., Štepec S., Lunar M., Poljak M. Hepatitis C virus genotypes in 1504 patients in Slovenia, 1993 to 2007. J. Med. Virol. 2009, 81:634-639.
18. Simmonds P., Kurtz J., Tedder R.S. The UK blood transfusion service: over a (patent) barrel?. Lancet 2002, 359:1713-1714.
19. Stramer S.L., Glynn S.A., Kleinman S.H., Strong D.M., Caglioti S., Wright D.J., Dodd R.Y., Busch M.P. Detection of HIV-1 and HCV infections among antibody negative blood donors by nucleic acid-amplification testing. N. Engl. J. Med. 2004, 351:760-768. National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group.
20. Velati C., Romanò L., Fomiatti L., Baruffi L., Zanetti A.R., SIMTI Research Group Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008, 48:2205-2213.
21. Vermeulen M., Lelie N., Sykes W., Crookes R., Swanevelder J., Gaggia L., Le Roux M., Kuun E., Gulube S., Reddy R. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009, 49:1115-1125.